title: Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
authors.forename: Hyun Seung
authors.initials: HS
authors.lastname: Yang
authors.forename: So Hyun
authors.initials: SH
authors.lastname: Park
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002829:Choroid / Q000473:pathology; D003930:Diabetic Retinopathy / Q000601:surgery; D018450:Disease Progression; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D017075:Laser Coagulation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012163:Retinal Detachment / Q000150:complications; D055213:Retinal Pigment Epithelium / Q000473:pathology; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab